Faculty Information - SHIRAKAWA Hiroki

（Last updated : 2025-03-03 15:43:10）

SHIRAKAWA Hiroki
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology

Position Assistant Professor

■ Published papers

1.	Original article	Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. 2023/05/04
2.	Original article	Long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation: The Japan academic consortium of kidney transplantation study-II. 2023/05
3.	Original article	Post-donation satisfaction in kidney transplantation: a survey of living donors in Japan 2019/10/26
4.	Original article	Predictors of return to work after kidney transplantation: a 12-month cohort of the Japan Academic Consortium of Kidney Transplantation study 2019/10/03
5.	Original article	Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible:A randomized trial. 2018/12
6.	Case report	Donor with membranous nephropathy in preemptive, living-related kidney transplantation. 2016/12
7.	Original article	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2016/07
8.	Original article	Preemptive living donor kidney transplantation and kidney function at the initial hospital visit: A single-center casee-control study. 2016/04
9.	Original article	Utility of the Japanese glomerular filtration rate equation in estimating glomerular filtration rate of donor kidney. 2016/04
10.	Original article	ABO-Incompatible living kidney transplants: Evolution of outcomes and immunosuppressive management. 2016/03
11.	Original article	Effects of low-dose rituximab therapy in patients with primary cytomegalovirus infection. 2015/12
12.	Original article	Plasma cell-rich rejection after kidney transplantation and the role of donor-specific antibodies: A case report and review of the literature. 2015/10
13.	Case report	Three cases of spindle cell renal cell carcinoma in hemodialysis patients. 2015/10
14.	Original article	Acute vascular rejection after renal transplantation and isolated v-lesion 2012/07
15.	Original article	Clinical and pathological analysis of transplant glomerulopathy cases 2012/07
16.	Original article	The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience 2011/11
17.	Original article	Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy 2011/02
18.	Original article	BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report 2011
19.	Original article	Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus(CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors 2011
20.	Original article	Mild rhabdomyolysis after renal transplantation 2011
21.	Original article	Bladder function of end-stage renal disease patients 2010/09
22.	Original article	Clinicopathological analysis of acute vascular rejection cases after renal transplantation. 2010/07
23.	Original article	Changes in anti-HLA antibody titers more than 1 year after desensitization therapy with rituximab in living-donor kidney transplantation. 2010
24.	Original article	Evaluation of Low-Dose Rituximab Induction Therapy in Living Related Kidney Transplantation. 2010
25.	Original article	New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT. 2010
26.	Original article	Retroperitoneoscopic living donor nephrectomy: experience of 425 cases at a single center. 2010
27.	Original article	Risk factors for deterioration of renal function after donor nephrectomy 2010
28.	Original article	Clinicopathological analysis of transplant glomerulopathy cases 2009/08
29.	Original article	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation:Long-term impact and risk factors 2009
30.	Original article	Association between antibody response against cytomegalovirus strain-specific glycoprotein H epitopes and HLA-DR 2009
31.	Original article	Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation 2009
32.	Original article	A case of plasma cell-rich acute rejection 18 months after kidney transplantation successfully treated with steroid pulse therapy 2008/07
33.	Original article	Persistent subclinical rejection associated with nodular B-cell infiltrates in a renal transplant recipient 2008/07
34.	Original article	Continent Orthotopic Ileal Neobladder After Kidney Transplantation in a Patient With Urothelial Cell Carcinoma Associated With Chinese Herb Nephropathy 2008/06
35.	Original article	Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation 2008/06
36.	Original article	Analysis of Renal Transplant Protocol Biopsies in ABO-Incompatible Kidney Transplantation 2008/01
37.	Original article	Clinical and Histological Analysis of Chronic Tacrolimus Nephrotoxicity in Renal Allografts 2008
38.	Original article	Evaluation of Immunosuppressive Regimens in ABO-Incompatible Living Kidney Transplantation-Single Center Analysis 2007/04
Display 5 items
Display all(38)

■ Academic conference presentation

1.	Long-term antibody response differences after SARS-CoV-2 vaccination in kidney transplant recipients and dialysis patients. 2024/09/14
2.	A case of Reiter's syndrome during intravesical BCG therapy. 2024/04/25
3.	The long-term renal outcome and pregnancy complications with kidney transplantation of IgA nephropathy. 2023/06/03
4.	The long-term renal outcome and pregnancy complications with kidney transplantation of IgA nephropathy. 2023/06/03
5.	A case of a solitary ruptured internal iliac artery aneurysm with suspected bladder rupture. 2023/04/22
6.	10-years long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation. 2023/04/20
7.	Antibody response after SARS-CoV-2 mRNA vaccines in previously infected kidney transplant recipients. 2022/11/26
8.	Preconception care and pregnancy complications after kidney transplantation: A single-center study. 2022/11/25
9.	The evaluation of neutrophil-to-lymphocyte ratio(NLR) in kidney transplant patients. 2019/09/15
10.	Pregnancy outcomes in kidney transplant recipients. 2019/06/03
11.	Evaluation of Urine BK Virus-PCR Measurement as a Screening Tool for Kidney Transplant Recipients 2018/11/24
12.	The Evaluation of Urine BK Virus PCR Measurement for Kidney Transplantation Recipients 2018/10/05
13.	Recurrence of immunoglobulin a nephropathy in related donor kidney transplant recipients. 2018/06/03
14.	Elevated levels of CD19+ B cells before or after rituximab administration is a risk factor for the early rejection of a living kidney transplant. 2018/06/02
15.	Neutrophil-Lymphocyte Ratio(NLR) is significantly decreased in kidney transplant patients: Is NLR a novel predictor of cardiovascular disease in kidney transplant patients? 2018/06/02
16.	Relation between seroprevalence of cytomegalovirus and graft survival in Japanese kidney transplant recipients: The Japan academic consortium of kidney transplantation study. 2018/06/02
17.	Medium-term outcomes of ABO-incompatible living kidney transplantation: Single center experience. 2017/09/27
18.	Surgical complications of living kidney transplantation: A single center experience. 2017/09/24
19.	Once-daily versus twice-daily tacrolimus in living kidney transplantation: A Multicenter, parallel group, open-label, 5-year, randomized non-inferiority trial. 2017/05/02
20.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: Evolution of outcomes and immunosuppressive management. 2016/10/29
21.	2 cases of reccurent IgA nephropathy after kidney transplantation. 2016/07/16
22.	Pathological course of treated BK virus nephropathy. 2016/07/16
23.	ABO-incompatible living kidney transplantation at multicenter Japanese case series: evolution of outcomes and immunosuppressive management. 2016/06/11
24.	Comparison of once-daily and twice-daily low-dose tacrolimus in living related kidney transplantation - Prospective trial of once-daily vs.twice-daily Tac - 5 years second report. 2016/06/11
25.	Utility of the Japanese glomerular filtration rate equation in estimating donor kidney. 2015/09/13
26.	Utility of the Japanese glomerular filtration rate equation in estimating donor kidney. 2015/08/23
27.	The clinical outcome of plasma cell-rich rejection of kidney allograft. 2015/05/05
28.	Long-term excellent results of ABO-incompatible kidney transplantations at multicenter Japanese case series. 2015/05/04
29.	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2015/05/03
30.	Intimal arteritis associated with subsequent graft dysfunction in ABO-incompatible kidney transplantation. 2015/05/02
31.	Long-term (more than 20 years) outcome of ABO-incompatible living donor kidney transplantation: A single center experience. 2014/07/29
32.	Risk factors of preterm delivery at less than 35 weeks in patients with kidney transplantation. 2014/07/29
33.	No necessity for prophylactic B-Cell-targeting treatment for postoperative high titers of anti-blood type antibodies after ABO-incompatible living related kidney transplantation. 2014/07/28
34.	Long-term outcomes of living donor kidney transplantation in flow cytometry crossmatch-positive patients: A single-center experience. 2014/07/27
35.	Preliminary outcome of desensitization with super high dose IVIG, plasmapheresis, and rituximab for crossmatch-positive (highly sensitized) kidney transplant recipients. 2014/07/27
36.	Falsely Elevated Blood Tacrolimus Concentrations Using The Affinity Column Mediated Immunoassay 2013/09/03
37.	Comparative Study of Adverse Events and Lymphocyte Recovery in Living Kidney Transplantation Patients Treated with/without Rituximab, a B Cell-Depleting Treatment 2013/05/21
38.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for over 20 Years 2013/05/21
39.	Microvascular Inflammation as a Core Element of Diagnostic Criteria of Antibody-Mediated Rejection(ABMR): C4d Positivity Is Not Reliable Element in Diagnosis of ABMR 2013/05/19
40.	Outcomes of Retroperitoneoscopic Procurement of Kidneys with Multiple Renal Arteries 2012/10/20
41.	Clinical and Pathological Analysis of Transplant Glomerulopathy Cases 2012/07/19
42.	Clinicopathological Analysis of Acute Vascular Rejection Cases after Renal Transplantation 2012/07/19
43.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation;a Single Center Experience for Over 20 Years 2012/07/19
44.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome(FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation 2012/07/19
45.	Quantitative Analysis of Humoral Immunity by Flow-Cytometric Crossmatch Combined with Molecules Equivalent Soluble Fluorochromosome (FCXM-MESF) for Classification of the Sensitization Status in Recipients of Renal Transplantation 2012/06/04
46.	Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation; a Single Center Experience for over 20 Years 2012/06/02
47.	Impact of Right-sided Nephrectomy on Long-term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy 2012/04/23
48.	Prophylactic therapy for antibody-mediated rejection during introductory period in kidney transplantation(Symposium7 Antibody-mediated rejection in kidney transplantation) 2012/02/03
49.	Chimerism of blood type antigens on the vessel endothelium in patients with antibody-mediated rejection 2011/09/04
50.	Impact and Implication of Renal Artery Number on Outcomes of Renal Donors and Recipients in Retroperitoneoscopic Live Donor Nephrectomy-Experience of 500 Cases at a Single Center 2011/05/03
51.	Impact of Right Nephrectomy on Long-Term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy:Experience of 479 Cases at a Single Center 2011/05/03
52.	Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 500 Cases at a Single Center 2011/05/03
53.	Excellent Outcomes of Rituximab Administration Plus Plasmapheresis as Prophylactic Treatment Prior to Kidney Transplantation in Patients with Focal Segmental Glomerulosclerosis 2011/05/02
54.	Decrease of Blood-Type Antigenicity over the Long-Term after ABO-Incompatible Kidney Transplantation 2011/05/01
55.	Significance of Qualitative and Quantitative Evaluations of Anti-HLA Antibodies in Kidney Transplantation 2011/05/01
56.	Significant Reduction in Chronic Antibody-Mediated Rejection after B-Cell Depleting Treatment in ABO-Incompatible Living Kidney Transplantation 2011/05/01
57.	Rituximab Therapy Reduces Peripheral B Cells for a Long Time in ABO Incompatible Kidney Transplantation; a Single Center Experience 2011/04/30
58.	Clinicopathological analysis of acute vascular rejection cases after renal transplantation 2010/05
59.	Marked improvement of the outcome of ABO-incompatible living kidney transplantation under current immunosuppressive 2010/05
60.	New-onset diabetes after transplantaion in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT 2010/05
61.	Outcome of retroperitoneoscopic living donor nephrectomy in obese donors 2010/05
62.	Surgical complications of pediatric kidney transplantation:A single center experience 2010/05
63.	The Low dose rituximab preconditioning in ABO-incompatible kidney transplantation: A 3-year follow up 2010/05
Display 5 items
Display all(63)

■ Education

1986/04～1992/03

Faculty of Medicine, Shimane Medical University, Graduated,